参考文献/References:
[1] Guarente L.The Logic Linking Protein Acetylation and Metabolism[J].Cell Metabolism,2011,14(2):151-153.
[2] Gray SG.Role of histone and transcription factor acetylation in diabetes pathogenesis[J].Diabetes Metab Res Rev,2005, 21(5): 416-433.
[3] 蒋智文,刘新光,周中军.组蛋白修饰调节机制的研究进展[J].生物化学与生物物理进展, 2009, 36(10): 1252-1259.
[4] Lundh M, Christensen DP,Rasmussen DN,et al. Lysine deacetylases are produced in pancreatic beta cells and are differentially regulated by proinflammatory cytokines[J].Diabetologia,2010, 53(12):2569-2578.
[5] Bramswig NC,Kaestner KH.Transcriptional and epigenetic regulation in human islets[J].Diabetologia,2014,57(3):451-454.
[6] Haberland M, Montgomery RL,Olson EN.The many roles of histone deacetylases in development and physiology: implications for disease and therapy[J].Nat Rev Genet, 2009, 10(1): 32-42.
[7] Bonnefond A,Froguel P,Vaxillaire M.The emerging genetics of type 2 diabetes[J].Trends Mol Med,2010, 16(9):407-416.
[8] Ashcroft FM,Rorsman P.Diabetes and the β cell:the last ten years[J].Cell,2012,148(6):1160-1171.
[9] Wang XJ, Wei XB,Pang Q,et al.Histone deacetylases and their inhibitors: molecular mechanisms and therapeutic implications in diabetes mellitus[J].Acta Pharmaceutica Sinica B,2012,2(4):387-395.
[10] Guo S,Burnette R,Zhao L,et al.The stability and transactivation potential of the mammalian MafA transcription factor areregulated by serine 65 phosphorylation[J].J Biol Chem,2009,284(2):759-765.
[11] 李丽萍,曾为民,郭明日.SIRT l的生物学功能及其在胰岛素抵抗中的作用[J].Science Research,2010,14(4):372-376.
[12] Ramsey KM,Mills KF,South A,et al.Age-associated loss of SIRT l-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific SIRT1-overexpressing(BESTO)mice[J].Aging Cell,2008,7(1):77-88.
[13] 郑伟,邓林,吴思思,等. 去乙酰化酶SIRT1对胰岛B细胞株MIN6分泌功能的影响及其机制研究[J].中南药学, 2010,8(5):332-335.
[14] Bruce KD, Hanson MA. The developmental origins, mechanisms, and implications of metabolic syndrome[J].J Nutr, 2010,140(3): 648-652.
[15] Jim Chillaron JC, Isganaitis E, Charalambous M, et al. Intergenerational transmission of glucose in tolerance and obesity by in utero undernutrition in mice[J].Diabetes, 2009, 58(2): 460-468.
[16] Pinney SE,Jaeckle Santos LJ,Han Y,et al.Exendin-4 increases histone acetylase activity and reverses epigenetic modifications that silence Pdx1 in the intrauterine growth retarded rat[J].Diabetologia,2011, 54(10):2606-2614.
[17] Christensen DP,Dahllöf M, Lundh M,et al.Histone deacetylase(HDAC)inhibition as a novel treatment for diabetes mellitus[J].Molmed,2011,17(5-6):378-390.
[18] Jiang GX, Cui YF, Zhong XY,et al.Use of a cocktail regimen consisting of soluble galectin-1, rapamycin and histone deacetylase inhibitor may effectively prevent type 1 diabetes[J].Arch Med Res,2009,40(5): 424-426.
[19] Patel T, Patel V, Singh R, et al.Chromatin remodeling resets the immune system to protect against autoimmune diabetes in mice[J].Immunol Cell Biol,2011,89(5):640-649.
[20] Susick L, Senanayake T, Veluthakal R, et a.l A novel histone deacetylase inhibitor prevents IL-1 beta induced metabolic dysfunction in pancreatic beta-cells[J].J Cell Mol Med, 2009,13(8B):1877-1885.
[21] Lewis EC, Blaabjerg L, Storling J,et al.The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet beta-cells in vivo and in vitro[J].Mol Med,2010,17(5-6):369-377.
[22] Matsuyama A,Shimazu T,Sumida Y,et al.In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation[J].EMBO J,2002,21(24):6820-6831.
[23] Outeito TF,Kontopoulous E,Altmann SM,et al.Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease[J].Science,2007,317(5837):516-519.
相似文献/References:
[1]李春睿,王静,陈峰,等.GLP-1受体激动剂对糖尿病患者肾功能的影响[J].国际内分泌代谢杂志,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
Li Chunrui*,Wang Jing,Chen Feng,et al.Effects of GLP-1 receptor agonists on renal function of diabetics[J].International Journal of Endocrinology and Metabolism,2014,(05):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
[2]黄珊珊,鲁一兵.长链非编码RNA与糖尿病[J].国际内分泌代谢杂志,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
Huang Shanshan*,Lu Yibing..Long non-coding RNA and diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(05):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
[3]高瑞霄,姚朱华,冯凭,等.尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义[J].国际内分泌代谢杂志,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
Gao Ruixiao*,Yao Zhuhua,Feng Ping,et al.The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease[J].International Journal of Endocrinology and Metabolism,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
[4]郑佳,肖新华.葡萄糖稳态的中枢调控作用机制
——2014年美国糖尿病协会“杰出科学成就奖”
演讲报告解读[J].国际内分泌代谢杂志,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
Zheng Jia,Xiao Xinhua.The mechanisms of central nervous system in the control of glucose homeostasis--A summary of 2014 ADA "Outstanding Scientific Achievement Award" Lecture[J].International Journal of Endocrinology and Metabolism,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
[5]卢婷婷,任思佳,沈捷.人群迁徙对糖尿病患病率的影响及其相关因素[J].国际内分泌代谢杂志,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
Lu Tingting,Ren Sijia,Shen Jie..Impact of migration on prevalence of diabetes and risk factors[J].International Journal of Endocrinology and Metabolism,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
[6]包薇萍,陈国芳,刘超.DPP-4抑制剂的肾保护作用[J].国际内分泌代谢杂志,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
Bao Weiping,Chen Guofang,Liu Chao..Renal protective effects of dipeptidyl peptidase-4 inhibitors[J].International Journal of Endocrinology and Metabolism,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
[7]孟庆冬,陶红.巨噬细胞凋亡与糖尿病动脉粥样硬化[J].国际内分泌代谢杂志,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
Meng Qingdong,Tao Hong..Macrophage apoptosis and diabetic atherosclerosis[J].International Journal of Endocrinology and Metabolism,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
[8]赵荷珺 洪天配.胰高血糖素样肽-1类药物与胰腺安全性[J].国际内分泌代谢杂志,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
Zhao Hejun*,Hong Tianpei..Glucagon-like peptide-1-based therapies and pancreatic safety[J].International Journal of Endocrinology and Metabolism,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
[9]吕丹 李晓思 陈树春 王泽普.Betatrophin:糖尿病再生治疗的新希望[J].国际内分泌代谢杂志,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
Lyu Dan*,Li Xiaosi,Chen Shuchun,et al.Betatrophin:new hope for regeneration therapy of diabetes[J].International Journal of Endocrinology and Metabolism,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
[10]陈金安 柳岚 蒋克春 王爱萍.糖尿病足溃疡中趋化因子的作用及机制[J].国际内分泌代谢杂志,2015,(05):357.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.018]
Chen Jinan,Liu Lan,Jiang Kechun,et al.Roles of chemokines in diabetic foot ulcer and the mechanisms[J].International Journal of Endocrinology and Metabolism,2015,(05):357.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.018]